A Novel Synthetic Smoothened Antagonist Transiently Inhibits Pancreatic Adenocarcinoma Xenografts in a Mouse Model

• Martin F. Strand ,

  * E-mail: martin.frank.strand@rr-research.no (MFS); stefan.krauss@rr-research.no (SK)

  Affiliation Unit for Cell Signalling, Institute for Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

  ⨯
• Steven R. Wilson,

  Affiliation Department of Chemistry, University of Oslo, Oslo, Norway

  ⨯
• Jennifer L. Dembinski,

  Affiliation Unit for Cell Signalling, Institute for Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

  ⨯
• Daniel D. Holsworth,

  Affiliation ChemDiv Inc., San Diego, California, United States of America

  ⨯
• Alexander Khvat,

  Affiliation ChemDiv Inc., San Diego, California, United States of America

  ⨯
• Ilya Okun,

  Affiliation ChemDiv Inc., San Diego, California, United States of America

  ⨯
• Dirk Petersen,

  Affiliation Department of Chemistry, University of Oslo, Oslo, Norway

  ⨯
• Stefan Krauss

  * E-mail: martin.frank.strand@rr-research.no (MFS); stefan.krauss@rr-research.no (SK)

  Affiliation Unit for Cell Signalling, Institute for Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

  ⨯